The MYH3 gene gives instructions for a muscle protein used mainly before birth, helping muscles form and move normally as a baby develops. The protein made by this gene helps your cells build working muscle fibers. If a harmful variant changes how it works, a child may be born with stiff or fixed joints, limited movement, and sometimes facial differences, short stature, or curvature of the spine. These changes are linked to several inherited conditions, including forms of distal arthrogryposis.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the directions for making proteins, the working parts of cells. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. If you want to go into this topic further, you can find more in the LearnHub.
Overview
MYH3Gene function
What if the gene works
The MYH3 gene helps build an early muscle protein used before birth. It supports normal skeletal muscle development and movement, including how developing joints and limbs move as a baby grows.
Risk
What if the gene does not work
Variants in the MYH3 gene most often cause forms of distal arthrogryposis, with congenital joint contractures and characteristic facial or spinal features. Effects can range from milder hand and foot tightening to more marked limb, face, and spine involvement.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic or loss-of-function variant in the MYH3 gene, and no MYH3-specific management approach is established.
Conditions associated with MYH3
Gene function
What if the gene works
Before birth, growing muscles need a pulling system so the body can start making coordinated movements. The MYH3 gene helps supply an early muscle protein used mainly in developing skeletal muscles. Understanding how the MYH3 gene works helps explain how your cells build and use muscle fibers in an organized way.
The protein from the MYH3 gene acts like part of a tiny motor in developing skeletal muscle cells. It helps those cells shorten and generate force for muscle contraction.
Inside young muscle cells, MYH3 helps arrange the repeating parts that let muscle fibers contract smoothly. This supports the orderly structure muscles need as they form before birth.
MYH3 is used mainly during fetal development, when skeletal muscles are growing and starting to coordinate movement. This is a key part of how the MYH3 gene supports muscle development before birth.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the MYH3 gene change the shape or stability of the myosin protein, so it may bind actin less well, use energy less efficiently, or assemble abnormally inside developing muscle cells. This is how variants in the MYH3 gene affect protein function during early muscle development. Some changes have a milder effect, while others disrupt the protein more strongly, which can influence how early contractures appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the MYH3 gene are a well-established cause of several forms of distal arthrogryposis, especially Freeman-Sheldon syndrome and Sheldon-Hall syndrome, which involve joint contractures present from birth. Some MYH3 gene variants are also linked to a condition with congenital contractures, short stature, and spinal changes. When a disease-causing MYH3 variant is found in the right clinical setting, it can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MYH3, risk is mainly linked to whether a disease-causing variant is present, often because it runs in the family or starts new in a child. There is not yet broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of a MYH3-related condition.
Inheritance of MYH3 variants
MYH3-related conditions are usually inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing variant in the MYH3 gene has a 50% chance of passing it on in each pregnancy, to a son or a daughter. Some cases of MYH3 gene inheritance happen because of a new (de novo) variant, so the change appears in the child without being inherited from either parent.
What does my MYH3 result mean for my family?
For MYH3, a disease-causing result is usually linked to a dominant pattern, so close relatives such as parents, siblings, and children may also carry the same variant and may want to learn whether it is present in the family. If a parent carries it, each child has a 1 in 2 chance of inheriting it. Some MYH3 changes happen new in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MYH3 variants usually uses a blood sample, saliva, or a cheek swab to read the MYH3 gene and look for changes linked to inherited muscle and joint conditions. Results may show a known disease-causing variant, a benign variant, or a variant of uncertain significance, meaning the result is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the MYH3 gene may be worth considering when a baby is born with several stiff or fixed joints, clubfoot, or certain facial or spine changes, or when these features run in the family. It can help confirm whether a change in MYH3 is the cause and clarify the chance of it happening again in relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, though how much it explains depends on the condition and the specific type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may not work the same way for everyone. Some people break down a drug faster or slower, while others are more or less sensitive to its effects. These common inherited differences can influence how much benefit a medicine provides and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies gene and drug patterns to understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the MYH3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so medication questions, side effects, or concerns about starting or changing treatment are best discussed with your doctor or pharmacist.